Table 1 Clinical features and prognosis of patients with Staphylococcus warneri endocarditis reported in the literature
From: Recurrent Staphylococcus warnerii prosthetic valve endocarditis: A case report and review
Reference | Age/Gender | Predisposing condition | Valve involved | Presence of vegetation on echocardiography | Antibiotics and duration of therapy |
|---|---|---|---|---|---|
4(1984) | 32/M | none | Aortic valve | Yes | Penicilin+ Gentamicin (4 weeks) |
6(1989) | 66/M | disc prosthesis** | Mitral, Aortic Valve | yes | NA* |
3(1992) | 64/M | none | Mitral, Aortic Pulmonary Valve | No | Vancomicin+ Gentamicin |
7(2001) | 71/M | Prosthetic aortic valve | Prosthetic aortic valve | yes | Vancomicin+ pefloxacine (6 weeks) |
9(2006) | 48/M | disc prosthesis** | Aortic valve | yes | Vancomicin+Fucidic acid (three day) Then Rifampicin+Fucidic acid |
10(2011) | 78/W | none | Mitral valve | yes | Nafcicillin (6 weeks) |
PRESENT CASE(2008) | 43/W | Prosthetic aortic valve, silicon mamoplasty** | Prosthetic aortic valve | yes | Ampicillin/sulbactam+ Gentamicin 2 weeks, Then 4 weeks amp/sulb. Ampicilin/sulbactam ampicillin/sulbactam (8 weeks) Not done |